Changjun Yin
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Circular RNAs in diseases 8
- DNA Repair Mechanisms 7
-
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 10
- Co-authors
- Chao Qin (73 shared papers)Meilin Wang (39 shared papers)Xiaobing Ju (34 shared papers)Sarajo K. Mohanta (17 shared papers)Andreas J. R. Habenicht (16 shared papers)Pengfei Shao (39 shared papers)Xiaoxin Meng (31 shared papers)Qiang Cao (35 shared papers)
- Journals
- PLoS ONE (17 papers)DNA and Cell Biology (5 papers)Asian Journal of Andrology (4 papers)European Urology (4 papers)Tumor Biology (4 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Changjun Yin
146 papers receiving 3.6k citations
Changjun Yin's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 937
- Immunology 537
- Reproductive Medicine 185
- Molecular Biology 1.5k
- Pulmonary and Respiratory Medicine 552
Countries citing papers authored by Changjun Yin
This map shows the geographic impact of Changjun Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjun Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjun Yin more than expected).
Fields of papers citing papers by Changjun Yin
This network shows the impact of papers produced by Changjun Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjun Yin. The network helps show where Changjun Yin may publish in the future.
Co-authors
The 25 scholars most cited alongside Changjun Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 138 | |
| 2 | 2014 | 132 | |
| 3 | 2013 | 123 | |
| 4 | 2017 | 102 | |
| 5 | 2014 | 101 | |
| 6 | 2015 | 101 | |
| 7 | 2016 | 100 | |
| 8 | 2014 | 92 | |
| 9 | 2012 | 91 | |
| 10 | 2019 | 80 | |
| 11 | 2016 | 78 | |
| 12 | CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis Hit paper breakdown → | 2024 | 76 |
| 13 | 2012 | 73 | |
| 14 | 2013 | 70 | |
| 15 | 2014 | 66 | |
| 16 | 2015 | 60 | |
| 17 | 2010 | 56 | |
| 18 | 2023 | 55 | |
| 19 | 2013 | 54 | |
| 20 | 2013 | 51 |
About Changjun Yin
Changjun Yin is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Immunology, having authored 150 papers that have together received 3.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Bladder and Urothelial Cancer Treatments (12 papers), Cancer-related molecular mechanisms research (10 papers), Renal cell carcinoma treatment (10 papers), Atherosclerosis and Cardiovascular Diseases (10 papers), Circular RNAs in diseases (8 papers), DNA Repair Mechanisms (7 papers) and Urologic and reproductive health conditions (6 papers). The work is most often cited by research in Cancer Research (937 citations), Immunology (537 citations), Reproductive Medicine (185 citations), Molecular Biology (1.5k citations) and Pulmonary and Respiratory Medicine (552 citations). Changjun Yin has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Chao Qin, Meilin Wang, Xiaobing Ju, Sarajo K. Mohanta, Andreas J. R. Habenicht, Pengfei Shao, Xiaoxin Meng, Qiang Cao, Zhengdong Zhang and Christian Weber. Their work appears in journals such as PLoS ONE, DNA and Cell Biology, Asian Journal of Andrology, European Urology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.